AA
Andrew J. Armanino

Andrew J. Armanino insider trades: Better Therapeutics (BTTX) stock purchases

Better Therapeutics Last trade Jul 27, 2023 41 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2020
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Andrew reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 27, 2023BTTX↑ Buy$200K
May 12, 2023CALB↑ Buy$40K
Apr 10, 2023BTTX↑ Buy$250K
Jun 14, 2022BTTX↑ Buy$21K
Jun 9, 2022BTTX↑ Buy$41K
Mar 29, 2022BTTX↑ Buy$86K
Dec 13, 2021BTTX↑ Buy$115K
Nov 29, 2021BTTX↑ Buy$118K
Jul 30, 2020CALB↑ Buy$20K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Andrew J. Armanino's insider trades

Andrew J. Armanino is an insider at Better Therapeutics (BTTX). Since Jul 30, 2020, Andrew has reported 9 open-market purchases worth $892K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (32 filings), other transactions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BTTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.